Pharmaceutical News

RSS

Xirrus deploys high performance Wi-Fi Arrays at EMA

Xirrus, the only Wi-Fi Power Play in the industry, announced today the deployment of Xirrus high performance Wi-Fi Arrays at the European Medicines Agency.

24 Mar 2011

FTC: Granting pharmacists authority over PBMs may increase drug prices, reduce competition

In a letter to Mississippi State Representative Mark Formby this week, the Federal Trade Commission warns that a bill shifting regulatory authority over pharmacy benefit managers from the Mississippi Insurance Commissioner to the Board of Pharmacy "may increase pharmaceutical prices and reduce competition."

24 Mar 2011

House bill proposes immunity for negligent drug manufacturers

Rep. Johnathan Rhyne, Republican Chairman of the NC House Select Committee on Tort Reform, today launched an assault on patients rights, adding provisions to favor insurance companies and drug manufacturers to a controversial Senate bill.

24 Mar 2011

Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.

24 Mar 2011

Oral contraceptive use before pregnancy does not pose respiratory problems in children

A new study by researchers at RTI International, the National Institute of Environmental Health Sciences, and the Norwegian Institute of Public Health refutes previous findings that oral contraceptive use before pregnancy is linked to respiratory problems in children.

24 Mar 2011

New report shows 2% decrease in anxiolytic and hypnotic sales in Norway

After many years of gradual increase followed by a three-year levelling off period, sales of addictive anxiolytic and hypnotic drugs decreased by just under two per cent in 2010.

24 Mar 2011

NephRx receives new U.S. patent for NX002 to treat IBD

NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease.

24 Mar 2011

New research: Methadone can affect brain and impair intellectual functions

Methadone has been used to treat heroin addicts for nearly 50 years. Yet we have surprisingly incomplete knowledge about possible harmful effects from prolonged use. New research from the Norwegian Institute of Public Health shows that methadone affects the brain and impairs the attention of experimental animals.

24 Mar 2011

USPTO grants patent to ULURU's Altrazeal product

ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.

24 Mar 2011

Ansell announces substantial price increase for NRL medical gloves

Following a continued increase of raw materials costs, Ansell Medical Solutions Europe, the regional branch of the world leader in hand protective solutions for healthcare professionals, has announced substantial price increases for its entire range of NRL medical gloves.

23 Mar 2011

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

23 Mar 2011

NephRx receives new U.S. patent for NX002 to treat oral mucositis

NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

23 Mar 2011

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

23 Mar 2011

SGEN, Abbott enter collaboration agreement for ADC products

Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.

23 Mar 2011

POZEN files motion for Treximet patent litigation against Par

POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that it has filed a motion for a preliminary injunction seeking to prevent Par Pharmaceuticals, Inc. from launching a generic version of Treximet.

23 Mar 2011

SMR, RTU enter license agreement for RESCULA eye drops

Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.

23 Mar 2011

Milk allergy successfully treated with Xolair

A latest study suggests that children with severe milk allergies may be able to rapidly overcome their sensitivities with the help of a biologic drug that helps to quiet an overly aggressive immune response. This is a small study still waiting to be proved in larger populations say researchers.

22 Mar 2011

Multivitamin supplements can optimize body's metabolic performance

Eating well is a difficult task for most people given the frantic pace of everyday living. Convenient pre-packaged and fast foods, rich in calories and low in nutrients, offer an easy solution to those short on time, but neglect to provide daily essential nutrients. And the short-changing of necessary nutritional requirements for good health is furthered by routine stress itself.

22 Mar 2011

USP teams up with FDA, CHPA to update quality standards for common medications

As part of its ongoing mission to protect public health, the U.S. Pharmacopeial Convention is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients.

22 Mar 2011

Researchers launch free online Atlas of TB vaccination policies around the world

Tuberculosis continues to pose a major global health threat. Someone in the world is newly infected with TB bacteria every second. Every year, more than 9 million people develop active TB and it claims about 2 million lives.

22 Mar 2011